NNK 是一种尼古丁亚硝化衍生物,激活 ERK1/2和 PKCα,并在 Ser70 激活 Bcl2磷酸化,以及在 Thr58和 Ser62激活 c-Myc。NNK能够诱导人肺癌细胞的增殖和存活,用于构建肺癌小鼠模型。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | NNK, a nitrosated derivative of nicotine, concurrently induces phosphorylation of Bcl2 uniquely at Ser70 and c-Myc at Thr58 and Ser62 via activation of both ERK1/2 and PKCα[1]. NNK promotes the survival and proliferation of human lung cancer cells and can be utilized in constructing lung cancer mouse models[2]. |
| 体外研究 | NNK (100 pM; 0-60 min) triggers the activation of PKCα and MAPKs ERK1/2, which directly leads to c-Myc phosphorylation[1]. NNK (100 pM; 96 hours) boosts the proliferation of cells expressing wild-type (WT) but not the AA mutant of c-Myc[1]. |
| Concentration | Treated Time | Description | References | |
| MLE-12 cells | 10 µM | 24 hours | NNK significantly increased AGT protein expression. | Exp Mol Med. 2023 Jun;55(6):1131-1144 |
| DMS79 cells | 10 µM | 48 and 72 hours | NNK treatment significantly increased DNMT1 expression | Sci Rep. 2018 Mar 20;8(1):4903 |
| A549 | 10 mM | 12 hours | NNK upregulated CD36 expression and promoted cell proliferation, migration, and invasion. | iScience. 2023 Jul 27;26(8):107477 |
| Bet1A | 10 mM | 12 hours | NNK upregulated CD36 expression and promoted cell proliferation, migration, and invasion. | iScience. 2023 Jul 27;26(8):107477 |
| NCI-H23 | 10 mM | 12 hours | NNK upregulated CD36 expression and promoted cell proliferation, migration, and invasion. | iScience. 2023 Jul 27;26(8):107477 |
| Alveolar type II cells | 0.1 µM and 1.2 µM | 180 minutes | To study the metabolism of NNK in the lung and the distribution of its metabolites, it was found that NNK is metabolized in the lung primarily through detoxification pathways, with approximately 55% of metabolites formed through detoxification pathways and roughly 30% through bioactivation pathways. | Drug Metab Dispos. 2010 May;38(5):752-60 |
| HBEL/p53i cells | 10 µM | 2 weeks | NNK significantly increased foci formation, which was significantly abrogated by treatment with an ACE inhibitor or AGTR1 antagonist. | Exp Mol Med. 2023 Jun;55(6):1131-1144 |
| BEAS-2B cells | 10 µM | 24 hours | NNK induced AGT expression and secretion of AngII, leading to the acquisition of transformed phenotypes in lung epithelial cells. | Exp Mol Med. 2023 Jun;55(6):1131-1144 |
| H1299 | 10 µM | 24 hours | NNK increased DNMT1 protein levels and resulted in hypermethylation of TSG promoters | J Clin Invest. 2010 Feb;120(2):521-32 |
| A549 | 10 µM | 24 hours | NNK increased DNMT1 protein levels and resulted in hypermethylation of TSG promoters | J Clin Invest. 2010 Feb;120(2):521-32 |
| IMR90 | 10 µM | 24 hours | NNK increased DNMT1 protein levels and resulted in hypermethylation of TSG promoters | J Clin Invest. 2010 Feb;120(2):521-32 |
| BEAS-2B cells | 50, 100, 200 mg/L | 24 hours | To detect the expression level of RRM2-C2orf48 in BEAS-2B cells after NNK treatment, results showed that 200 mg/L dose significantly upregulated RRM2-C2orf48 expression | iScience. 2022 Dec 2;26(1):105708 |
| BEAS-2B cells | 50, 100, 200, 400 mg/L | 24 hours | To assess the effect of NNK on the viability of BEAS-2B cells, results showed that NNK reduced cell viability in a dose-dependent manner | iScience. 2022 Dec 2;26(1):105708 |
| H1299 cells | 100 pM | 24 hours | NNK significantly enhances migration and invasion of H1299 cells and accelerates wound healing. | Cancer Lett. 2012 May 1;318(1):106-13 |
| B-Vector cells | 265.04 µM | 24 hours | Evaluate the cytotoxicity of NNK in B-Vector cells, results showed B-Vector cells were moderately sensitive to NNK | Molecules. 2022 Jul 29;27(15):4851 |
| B-2A13 cells | 24.52 µM | 24 hours | Evaluate the cytotoxicity of NNK in B-2A13 cells, results showed B-2A13 cells were more sensitive to NNK | Molecules. 2022 Jul 29;27(15):4851 |
| BEAS-2B cells | 376.14 µM | 24 hours | Evaluate the cytotoxicity of NNK in BEAS-2B cells, results showed BEAS-2B cells were less sensitive to NNK | Molecules. 2022 Jul 29;27(15):4851 |
| FaDu (human hypopharyngeal squamous cancer cells) | 1 µM and 2 µM | 24 hours | To investigate the effect of NNK on MSH2 and MLH1 protein and mRNA expression in FaDu cells. Results showed that NNK significantly upregulated miR-21 and miR-155, downregulated miR-422a, and reduced MSH2 and MLH1 protein and mRNA expression. Inhibition of miR-21 restored NNK-induced reduction in MSH2 expression. | Cells. 2020 Apr 21;9(4):1031 |
| NCI-H1703 (human lung squamous cancer cells) | 1 µM and 2 µM | 24 hours | To investigate the effect of NNK on MSH2 and MLH1 protein and mRNA expression in NCI-H1703 cells. Results showed that NNK significantly upregulated miR-21 and miR-155, downregulated miR-422a, and reduced MSH2 and MLH1 protein and mRNA expression. Inhibition of miR-21 restored NNK-induced reduction in MSH2 expression. | Cells. 2020 Apr 21;9(4):1031 |
| Het-1A cells | 1 µM | 24 hours | NNK stimulated expression of oncogenic genes, including ETS1, NRAS and SRC, which could be abolished in the presence of rSLURP-1. | Life Sci. 2012 Nov 27;91(21-22):1122-5 |
| BEP2D cells | 1 µM | 24 hours | NNK stimulated expression of oncogenic genes, including MYB and PIK3CA, which could be abolished in the presence of rSLURP-1. | Life Sci. 2012 Nov 27;91(21-22):1122-5 |
| MRC-5 cells | 10 µM | 24, 48, and 72 hours | NNK treatment significantly reduced GRα mRNA and protein expression levels and caused accumulation of DNMT1 at GR promoters 1B and 1F | Sci Rep. 2018 Mar 20;8(1):4903 |
| Panc-1 | 1 µM | 24-48 hours | NNK significantly enhanced the colony formation ability and spherogenesis of pancreatic cancer cells, while increasing the expression levels of stem cell markers OCT-4, SOX-2, and Nanog. | Mol Oncol. 2022 Aug;16(15):2881-2895 |
| BxPC-3 | 1 µM | 24-48 hours | NNK significantly enhanced the colony formation ability and spherogenesis of pancreatic cancer cells, while increasing the expression levels of stem cell markers OCT-4, SOX-2, and Nanog. | Mol Oncol. 2022 Aug;16(15):2881-2895 |
| NCI-H23 cells | 10 µM | 28 days | To study the role of TCTP in NNK-induced EMT, results showed up-regulation of TCTP and vimentin expression | J Transl Med. 2020 Feb 11;18(1):66 |
| Bet1A cells | 10 µM | 28 days | To study the role of TCTP in NNK-induced EMT, results showed up-regulation of TCTP and vimentin expression | J Transl Med. 2020 Feb 11;18(1):66 |
| Beas-2B | 10 µM | 6 hours | DNMT1 protein returned to basal levels 2–6 hours after discontinuation of NNK treatment | J Clin Invest. 2010 Feb;120(2):521-32 |
| LLC | 25 µM | 72 hours | NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| EPLC-32M | 25 µM | 72 hours | NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| A549 | 25 µM | 72 hours | NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| 16HBE | 25 µM | 72 hours | NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| CAL-27 cells | 5 µM | 96 hours | NNK stimulates DEPDC1 expression by promoting the methylation of its gene body through increased DNMT1 expression in OSCC cells. | Am J Cancer Res. 2020 Jun 1;10(6):1745-1760 |
| HSC-3 cells | 5 µM | 96 hours | NNK stimulates DEPDC1 expression by promoting the methylation of its gene body through increased DNMT1 expression in OSCC cells. | Am J Cancer Res. 2020 Jun 1;10(6):1745-1760 |
| 2B-NNK cells | 100 mg/L | multiple exposures | To evaluate the effect of RRM2-C2orf48 overexpression on NNK-induced malignant transformation of BEAS-2B cells, results showed that RRM2-C2orf48 overexpression accelerated malignant transformation | iScience. 2022 Dec 2;26(1):105708 |
| Administration | Dosage | Frequency | Description | References | ||
| Fischer 344 rats | Isolated perfused rat lung (IPRL) model | Perfusion | 0.1 μM and 1.2 μM | Single perfusion, lasting 180 minutes | To study the metabolism of NNK in the lung and the formation of DNA adducts, it was found that NNK is metabolized in the lung primarily through detoxification pathways, with approximately 55% of metabolites formed through detoxification pathways and roughly 30% through bioactivation pathways. The addition of PEITC significantly reduced the formation of oxidative metabolites and increased the formation of NNAL and the percentage of unmetabolized NNK. PEITC also significantly decreased the formation of DNA adducts in the lung tissue. | Drug Metab Dispos. 2010 May;38(5):752-60 |
| Mice | NNK-induced lung cancer model and K-rasLA1 transgenic mice | Intravenous injection | 10 μM | Once a week for 13 weeks (NNK model) or 5 weeks (K-rasLA1 model) | MiR-124 agomiR significantly suppressed NNK-induced and K-ras mutation-driven lung tumorigenesis | Mol Ther Nucleic Acids. 2017 Dec 15;9:145-154 |
| A/J mice | NNK-induced lung adenocarcinoma model | Intraperitoneal injection | 100 mg/kg | Every other day, three times, lasting for 16 weeks | NNK promoted lung adenocarcinoma development through CD36. | iScience. 2023 Jul 27;26(8):107477 |
| A/J mice | A/J mice | Intraperitoneal injection | 100 mg/kg | Single injection | To evaluate the protective effect of HB diet against NNK-induced lung tumorigenesis, results showed HB downregulated cyp2a4 and cyp2a5 mRNA expression and facilitated the formation of non-carcinogenic NNK metabolites | Pharmaceuticals (Basel). 2024 Nov 30;17(12):1615 |
| Mice | Pten +/− mice | Intraperitoneal injection | 100 mg/kg | Single dose or three doses weekly, lasting 16-24 weeks | To evaluate the effect of NNK on lung tumorigenesis in Pten +/? mice. Results showed that in lung tumor-susceptible pseudo–A/J mice, NNK treatment led to increased lung tumor size in Pten +/? mice but did not increase tumor multiplicity. In lung tumor-resistant C57BL/6 mice, NNK treatment did not induce lung tumors. | Neoplasia. 2008 Aug;10(8):866-72 |
| A/J and C3H mice | Lung tumor model | Intraperitoneal injection | 100 mg/kg/day | Every other day for three doses | To study the effect of NNK on lung tumorigenesis in A/J and C3H mice. Results showed that NNK induced lung tumors in A/J mice but not in C3H mice. | Am J Respir Cell Mol Biol. 2007 Jan;36(1):13-9 |
| A/J mice | Lung adenoma model | Intraperitoneal injection | 2 mg | Single injection, terminated 24 weeks after treatment | NNK induced increased expression levels of DNMT1, p-AKTser473, p-GSK3βser9, cytoplasmic hnRNP-U, and cytoplasmic βTrCP proteins | J Clin Invest. 2010 Feb;120(2):521-32 |
| Mice | Agt+/+ and Agt+/- mice | Oral gavage | 3 μmol | Twice a week for 20 weeks | NNK significantly increased the multiplicity, volume, and load of lung tumor nodules, and these changes were significantly suppressed in Agt+/- mice. | Exp Mol Med. 2023 Jun;55(6):1131-1144 |
| A/J mice | NNK-induced lung cancer model | Injection | 50 mg/kg | Twice, one week apart, for 20 weeks | To compare the efficacy of different fat types in ketogenic diets in preventing NNK-induced lung cancer. Results showed that the fish oil-enriched ketogenic diet (FO-KD) was most effective in reducing lung nodule numbers. | Sci Rep. 2024 Mar 7;14(1):5610 |
| A/J mice | Lung cancer model | Gavage | 50 mg/kg | Twice a week for 5 weeks | NNK significantly upregulated IDO1 expression in lung tissues and reduced CD8+T cells while increasing Tregs. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| Ferrets (Mustela putorius furo) | Human lung cancer model | Intraperitoneal injection | 50 mg/kg | Once a month for four consecutive months, followed by observation for 24, 26, and 32 weeks | To investigate whether NNK exposure alone induces both preneoplastic and neoplastic lesions in ferret lungs. Results showed that NNK exposure led to preneoplastic lesions (squamous metaplasia, dysplasia, and atypical adenomatous hyperplasia) and tumors (squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma) in ferret lungs, with tumor incidence being time-dependent (16.7%, 40.0%, and 66.7% at 24, 26, and 32 weeks, respectively). Additionally, NNK exposure significantly increased α7 nAChR protein expression and showed a tendency for increased phospho-ERK and cyclin D1 protein levels. | Lung Cancer. 2013 Dec;82(3):390-6 |
| A/J mice | NNK-induced lung cancer model | Intraperitoneal injection | 50 mg/kg | Two injections, one week apart, for 20 weeks | To investigate the inhibitory effect of soy saponins and isoflavones on NNK-induced lung nodule formation. Results showed that the combination of soy saponins and isoflavones significantly reduced the number of lung nodules and increased plasma isoflavone levels. | Sci Rep. 2025 Apr 13;15(1):12714 |
| Animal study | 肺肿瘤模型[3] 动物:A/J小鼠。 给药:100 mg/kg 在 0.1mL PBS 中 , 腹腔注射 ,每隔三天注射三剂 NNK。 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.83mL 0.97mL 0.48mL |
24.13mL 4.83mL 2.41mL |
48.26mL 9.65mL 4.83mL |
|
| CAS号 | 64091-91-4 |
| 分子式 | C10H13N3O2 |
| 分子量 | 207.23 |
| SMILES Code | O=C(C1=CC=CN=C1)CCCN(N=O)C |
| MDL No. | MFCD00274580 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | FLAQQSHRLBFIEZ-UHFFFAOYSA-N |
| Pubchem ID | 47289 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 60 mg/mL(289.53 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1